Registered number
10653564
REGENERATIVE PHARMA CONSULTING LTD
Accounts
31 March 2024
REGENERATIVE PHARMA CONSULTING LTD
Registered number: 10653564
Balance Sheet
as at 31 March 2024
2024 2023
£ £
Fixed assets 1,247 -
Current assets 6,166 7,816
Creditors: amounts falling due within one year (1,178) (3,021)
Net current assets 4,988 4,795
Total assets less current liabilities 6,235 4,795
Accruals and deferred income (500) -
Net assets 5,735 4,795
Capital and reserves 5,735 4,795
Number Number
Average number of employees 0 1
The company is a private company limited by shares and incorporated in England. Its registered office is Lyel Accountants Ltd Annexe G, Oaktree House, 408 Oakwood Lane, Leeds, England, LS8 3LG.
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Adam Ali
Director
Approved by the board on 30 October 2024
REGENERATIVE PHARMA CONSULTING LTD 10653564 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts October 2023 release 2 Adam Ali No description of principal activity 10653564 2022-04-01 2023-03-31 10653564 core:WithinOneYear 2023-03-31 10653564 2023-04-01 2024-03-31 10653564 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10653564 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10653564 countries:England 2023-04-01 2024-03-31 10653564 bus:Director40 2023-04-01 2024-03-31 10653564 bus:Micro-entities 2023-04-01 2024-03-31 10653564 bus:FullAccounts 2023-04-01 2024-03-31 10653564 2024-03-31 10653564 core:WithinOneYear 2024-03-31 10653564 2023-03-31 iso4217:GBP xbrli:pure